(Q36839875)

16 August 2017

1 reference

title

Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment (English)

1 reference

16 August 2017

arterial hypertension

1 reference

Proudman SM

1

1 reference

16 August 2017

Stevens WM

series ordinal

2

1 reference

16 August 2017

Sahhar J

series ordinal

3

1 reference

16 August 2017

Celermajer D

series ordinal

4

1 reference

16 August 2017

1 July 2007

1 reference

Internal Medicine Journal

16 August 2017

1 reference

16 August 2017

37

1 reference

16 August 2017

7

1 reference

16 August 2017

485-494

1 reference

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Clinical manifestations of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Diagnosis and differential assessment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Pathologic assessment of vasculopathies in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Predictors of end stage lung disease in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Isolated pulmonary hypertension in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Isolated diffusing capacity reduction in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Clinical and laboratory features of scleroderma patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Survival with first-line bosentan in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Frequency of Doppler measurable pulmonary artery pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2007.01370.X

10.1111/J.1445-5994.2007.01370.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference